Analysis of the TCGA database showed that expression of miR-142-3p and ROCK2 was significantly correlated with the survival time of GC patients after chemotherapy, which suggested that miR-142-3p and ROCK2 may also be involved in chemotherapeutic resistance in GC. The gene discussed is ROCK2; the disease is gastric cancer.